title: Neoadjuvant intravenous cisplatin for T2-4NxMo bladder cancer.
authors: Royal Prince Alfred Hospital, Sydney, Australia.
authors: D
authors: D
authors: Raghavan
authors: B
authors: B
authors: Pearson
authors: P
authors: P
authors: Duval
authors: J
authors: J
authors: Rogers
authors: H
authors: H
authors: Watt
authors: A
authors: A
authors: Tynan
mesh_terms: D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D002945:Cisplatin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D011879:Radiotherapy Dosage; D001743:Urinary Bladder / Q000601:surgery; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy
chemical_list: D002945:Cisplatin